Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (13027)	8/11/1998 2:33:00 AM
From: VLAD	Read Replies (1) \| Respond to of 23519

Notice the very last paragraph of the article. Pfizer's decision to place greed over safety will catch up with them in the long run. You see if Pfizer buckles in any way shape or form and suddenly says that men with CVD should avoid Viagra use they would be basically shooting themselves in the foot by admitting the very thing they have been denying all along. It would also give tons of credibility to any at risk patient who has experienced a heart attack shortly after taking Viagra. Pfizer can never afford to admit that Viagra is unsafe in CVD patients but in the long run they will not be able to keep denying that Viagra has some serious safety issues which need to be addressed. The way I see it, they have painted themselves in a corner and will never be able to get out of this situation smelling like roses.

To: VLAD who wrote (13027)	8/11/1998 9:31:00 AM
From: betty moyers	Read Replies (1) \| Respond to of 23519

Viagra Scripts in tabular form : (From BigKYN3's posting) WEEK NEW REFILL TOTAL 1 4/17 113,134 2,109 115,243 2 4/24 207,868 7,500 215,376 3 5/01 269,842 16,429 286,271 4 5/08 278,715 24,700 303,415 5 5/15 262,566 35,100 297,666 6 5/22 236,525 45,972 282,497 7 5/29 161,405 49,452 210,857 8 6/05 192,585 63,323 255,908 9 6/12 168,610 64,781 233,391 10 6/19 151,579 68,689 219,458 11 6/26 141,877 75,748 217,625 12 7/03 128,516 85,295 213,811 13 7/10 109,500 74,748 184,300 14 7/17 114,000 81,000 195,000 15 7/24 105,066 81,169 186,235 16 7/30 98,998 82,422 181,420 Yesterday, I felt like writing a sarcastic response to seeing these numbers. Quick call CNBC and tell them they need to blast the Pfizer CEO, Viagra's market has dropped 40%!!! and new patients are a mere one-third of the peak. Ah well, I guess it's not the same when you don't have a small company to pick on. The numbers clearly show the bloom is off the rose. The trend is down for Viagra and holding steady (maybe rising) for MUSE. A few more weeks data and we'll have a better picture for MUSE in US. As Ed told us some time ago, we aren't patient enough. It will take time to turn things around.